The New England Journal of Medicine today published the latest results from the European Randomised Study of Screening for Prostate Cancer (ERSPC) that commenced in 1991.
Since 1991, investigators led by prostate cancer screening expert: Dr Fritz H Schroder have followed 182,160 men who were randomly assigned one of two groups: (1) receive prostate specific antigen based prostate cancer screening or (2) no prostate cancer screening.
The research found that prostate cancer testing resulted in a 38% reduction of men dying from prostate cancer during the 11 year follow up period. Concluding, prostate cancer screening can reduce the death rate of prostate cancer by over a third if men are systematically screened over time.
In Australia each year, over 20,000 men are diagnosed with prostate cancer and over 3,300 die. The results reported indicate that the death rate from prostate cancer can potentially be decreased by over a third if men commit to prostate cancer testing during their lifetime.
Prostate Screen Prostate Screen Australia is a testing group currently based in Brisbane that offers men testing for prostate cancer in a supportive and specialist environment.
Click here to make an appointment online now. No referral required!